Research programme: ion channel modulators - ArQule

Drug Profile

Research programme: ion channel modulators - ArQule

Alternative Names: Ion channel modulators research programme - ArQule

Latest Information Update: 19 Jun 2006

Price : $50

At a glance

  • Originator ArQule
  • Class
  • Mechanism of Action Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Neuropathic pain

Most Recent Events

  • 12 Feb 2004 Ion channel modulator is available for licensing (http://www.arqule.com)
  • 13 Aug 2003 Preclinical trials in Neuropathic pain in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top